Source: Science Daily
12.10.2007
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than non-responders, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
External Link: http://www.sciencedaily.com/releases/2007/12/071210094351.ht...
